Abstract
Spatially addressable combinatorial libraries were synthesized by solution phase chemistry and screened for binding to human serum albumin. Members of arylidene diamide libraries were among the best hits found, having submicromolar binding affinities. The results were analyzed by the frequency with which particular substituents appeared among the most potent compounds. After immobilization of the ligands either through the oxazolone or the amine substituent, characterization by surface plasmon resonance showed that ibuprofen affected the binding kinetics, but phenylbutazone did not. It is therefore likely that these compounds bind to Site 2 in sub domain IIIA of human serum albumin (HSA).
Keywords: Affinity chromatography, combinatorial chemistry, high-throughput screening, arylidene diamide library, Ligands, macromolecules, structure-activity relationships, HPLC, Immobilization, Solution Phase Screening
Combinatorial Chemistry & High Throughput Screening
Title: Novel Affinity Ligands for Chromatography Using Combinatorial Chemistry
Volume: 14 Issue: 4
Author(s): Tor Regberg, Charlotta Lindquist, Ake Pilotti, Christel Ellstrom, Lars Fagerstam, Ann Eckersten, Yasuro Shinohara, Steven L. Gallion and Joseph C. Hogan
Affiliation:
Keywords: Affinity chromatography, combinatorial chemistry, high-throughput screening, arylidene diamide library, Ligands, macromolecules, structure-activity relationships, HPLC, Immobilization, Solution Phase Screening
Abstract: Spatially addressable combinatorial libraries were synthesized by solution phase chemistry and screened for binding to human serum albumin. Members of arylidene diamide libraries were among the best hits found, having submicromolar binding affinities. The results were analyzed by the frequency with which particular substituents appeared among the most potent compounds. After immobilization of the ligands either through the oxazolone or the amine substituent, characterization by surface plasmon resonance showed that ibuprofen affected the binding kinetics, but phenylbutazone did not. It is therefore likely that these compounds bind to Site 2 in sub domain IIIA of human serum albumin (HSA).
Export Options
About this article
Cite this article as:
Regberg Tor, Lindquist Charlotta, Pilotti Ake, Ellstrom Christel, Fagerstam Lars, Eckersten Ann, Shinohara Yasuro, L. Gallion Steven and C. Hogan Joseph, Novel Affinity Ligands for Chromatography Using Combinatorial Chemistry, Combinatorial Chemistry & High Throughput Screening 2011; 14(4) . https://dx.doi.org/10.2174/138620711795222482
DOI https://dx.doi.org/10.2174/138620711795222482 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Protein Tyrosine Phosphatase 1B Inhibition: Opportunities and Challenges
Current Medicinal Chemistry Synthesis and In-Vitro Antitumor Activity of Selected 7-Fluoro-6-(4-methyl-1-piperazinyl)-2-(thiosubstituted)-4(3H)-quinazolinones
Letters in Organic Chemistry Patent Selections
Recent Patents on Biomarkers Phenolics Constituents of Different Types of Propolis and their Antimicrobial Activities
Anti-Infective Agents Oxytocin: An Old Hormone, a Novel Psychotropic Drug and its Possible Use in Treating Psychiatric Disorders
Current Medicinal Chemistry SAR and Molecular Modeling of N-Benzyl-N-hydroxy-3-(cyclopentyloxy)-4- methoxybenzene Carboxamide Analogues as Potent Phosphodiesterase-4 Inhibitors
Letters in Drug Design & Discovery COVID 19, All a Radiologist Needs to Know: A Narrative Review
Current Respiratory Medicine Reviews Genetic and Epigenetic Diversity of Protein Molecules Related to SARSCoV- 2 Entry: Where We Are and Where We Should Go?
Current Protein & Peptide Science Thiophene Ring-opening Reactions III: One-Pot Synthesis and Antitumor Activity of 1,3,4-Thiadiazoline–Benzothiazolo[3,2-<i>b</i>]pyridazine Hybrids†
Current Organic Synthesis A Comprehensive Review on Fused Heterocyclic as DNA Intercalators: Promising Anticancer Agents
Current Pharmaceutical Design The Central Role of Angiotensin I-Converting Enzyme in Vertebrate Pathophysiology
Current Topics in Medicinal Chemistry Pharmacokinetic Properties and In Silico ADME Modeling in Drug Discovery
Medicinal Chemistry Chaperones & Co: Roles in Protein/Nucleic Acid Homeostasis
Current Proteomics The Histopathology of Spondyloarthropathy
Current Molecular Medicine The Nuclear Overhauser Effect in the Lead Identification Process Pharmacophore Models
Current Drug Discovery Technologies Selective Inhibition of Osteoclast Vacuolar H+-ATPase
Current Pharmaceutical Design Natural and Synthetic Compounds with an Antimycobacterial Activity
Mini-Reviews in Organic Chemistry Recent Advances of p53-MDM2 Small Molecule Inhibitors (2011-Present)
Current Medicinal Chemistry Beneficial Effects of N-acetylcysteine and N-mercaptopropionylglycine on Ischemia Reperfusion Injury in the Heart
Current Medicinal Chemistry Inhibitors of Nitric Oxide Synthase: What's up and What's Next?
Current Enzyme Inhibition